Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 382

1.

Moderately Elevated Blood Pressure: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Sep.

2.

Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication.

Mancia G, Cannon CP, Tikkanen I, Zeller C, Ley L, Woerle HJ, Broedl UC, Johansen OE.

Hypertension. 2016 Dec;68(6):1355-1364. Epub 2016 Oct 10.

PMID:
27977392
3.

Patient Management of Hypertensive Subjects without and with Diabetes Mellitus Type II.

Safar ME, Blacher J, Protogerou AD.

Med Clin North Am. 2017 Jan;101(1):159-167. doi: 10.1016/j.mcna.2016.08.014. Review.

PMID:
27884226
4.

Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study.

Karpov YA; FORTISSIMO physicians.

Clin Drug Investig. 2017 Feb;37(2):207-217. doi: 10.1007/s40261-016-0479-7. Erratum in: Clin Drug Investig. 2017 Jul 10;:.

PMID:
27878562
5.

Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.

Pelusi S, Petta S, Rosso C, Borroni V, Fracanzani AL, Dongiovanni P, Craxi A, Bugianesi E, Fargion S, Valenti L.

PLoS One. 2016 Sep 20;11(9):e0163069. doi: 10.1371/journal.pone.0163069. eCollection 2016.

6.

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.

van der Leeuw J, Visseren FL, Woodward M, van der Graaf Y, Grobbee DE, Harrap S, Heller S, Mancia G, Marre M, Poulter N, Zoungas S, Chalmers J.

Diabetologia. 2016 Dec;59(12):2603-2612. Epub 2016 Sep 1.

PMID:
27586250
7.

Recent trends in the use of antidiabetic medications from 2008 to 2013: A nation-wide population-based study from Taiwan.

Ou HT, Chang KC, Liu YM, Wu JS.

J Diabetes. 2017 Mar;9(3):256-266. doi: 10.1111/1753-0407.12408. Epub 2016 May 30.

PMID:
27062145
8.

Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.

Yavin Y, Mansfield TA, Ptaszynska A, Johnsson K, Parikh S, Johnsson E.

Diabetes Ther. 2016 Mar;7(1):125-37. doi: 10.1007/s13300-015-0150-y. Epub 2016 Jan 12.

9.

Antihypertensive Drugs and Diabetic Retinopathy in Patients with Type 2 Diabetes.

Lin JC, Lai MS.

Ophthalmologica. 2016;235(2):87-96. doi: 10.1159/000441958. Epub 2015 Dec 23.

PMID:
26695432
10.

Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score.

Woodward M, Hirakawa Y, Kengne AP, Matthews DR, Zoungas S, Patel A, Poulter N, Grobbee R, Cooper M, Jardine M, Chalmers J; ADVANCE Collaborative Group.

Diabetes Obes Metab. 2016 Mar;18(3):289-94. doi: 10.1111/dom.12614. Epub 2016 Jan 15.

PMID:
26661693
11.

Early intensive treatment improves outcomes in patients with glomerular hyperfiltration and type 2 diabetes.

Troya MI, Bonet J, Salinas I, Torres F, Bonal J, Sanmartí A, Romero R.

Med Clin (Barc). 2016 Jan 15;146(2):55-60. doi: 10.1016/j.medcli.2015.05.016. Epub 2015 Sep 3.

PMID:
26343155
12.

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.

Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group.

JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081.

PMID:
26325557
14.

[ADVANCE-ON Trial; How to Achieve Maximum Reduction of Mortality in Patients With Type 2 Diabetes].

Kanorskiĭ SG.

Kardiologiia. 2015;55(2):96-101. Review. Russian.

PMID:
26164995
15.

Effect of six years intensified multifactorial treatment on levels of hs-CRP and adiponectin in patients with screen detected type 2 diabetes: the ADDITION-Netherlands randomized trial.

den Ouden H, Berends J, Stellato RK, Beulens JW, Rutten GE.

Diabetes Metab Res Rev. 2015 Oct;31(7):758-66. doi: 10.1002/dmrr.2669. Epub 2015 Jul 30.

PMID:
26109470
16.
17.

[Treatment of hypertension in diabetes mellitus].

Widimský J Jr.

Vnitr Lek. 2015 Apr;61(4):335, 337-9. Czech.

PMID:
25894264
18.

Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.

Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, Matsuo S.

Clin Exp Nephrol. 2015 Dec;19(6):1098-106. doi: 10.1007/s10157-015-1106-2. Epub 2015 Mar 21.

19.

Use of antihypertensive medications in patients with type -2 diabetes in Ajman, UAE.

Arifulla M, John LJ, Sreedharan J, Muttappallymyalil J, Cheriathu J, Altaf Basha S.

Acta Med Iran. 2015;53(2):129-33.

20.

Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR.

Hanon O, Boully C, Caillard L, Labourée F, Cochiello S, Chaussade E.

Am J Hypertens. 2015 Aug;28(8):1064-71. doi: 10.1093/ajh/hpu297. Epub 2015 Jan 26.

PMID:
25628416

Supplemental Content

Loading ...
Support Center